HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch
Section

Pipeline

Late-stage drugs with significant commercial implications

Regeneron ushers in new genetic medicine era with groundbreaking gene therapy approval
PipelineFiercePharma ↗
Travis Smith was a very serious baby. Born completely unable to hear, his mother, Sierra, struggled to see his…
Apr 25, 2026
Novartis pulls Pluvicto prostate cancer label expansion filing in the EU
PipelineEndpoints News ↗
Novartis has withdrawn its EU application for Pluvicto's expansion into earlier prostate cancer treatment, des…
Apr 24, 2026
A CAR-T biotech’s dramatic turnaround, and drugmakers’ tactics to drive more scripts
PipelineSTAT News ↗
This week on "The Readout LOUD": a CAR-T biotech's dramatic turnaround, and drugmakers' tactics to drive more …
Apr 23, 2026
PipelineAJMC ↗
Apr 23, 2026
PipelineAJMC ↗
Apr 23, 2026
Merck amps up presence in HIV treatment market with FDA nod for novel combo pill Idvynso
PipelineFiercePharma ↗
The once-daily HIV treatment regimen offers a new mechanism of action in the HIV treatment market.…
Apr 23, 2026
← Newer Page 10 Older →
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.